Skip to main content
TOPICS
Videos
Podcasts
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
healthcare investment firm
OrbiMed scores more than $4.3B in private investment funds
By
Jessica Hagen
|
07:04 pm |
October 24, 2023
The investment firm's portfolio includes tech-enabled drug-discovery startup Insilico and fertility-benefits manager Carrot Fertility.
Investor: Time for health insurance companies to act like D2C businesses
By
Jonah Comstock
|
11:39 am |
October 01, 2014